Sign in
Taking people in United StatesPhase 1/2

App-guided mindfulness meditation at bedtime for adults with insomnia

Tests app-guided mindfulness meditation for sleep in adults with insomnia.

Key facts

Who runs it
Brigham and Women's Hospital
Where
Boston, United StatesSee the site
Trial code
Registry title
Mindfulness Meditation for Insomnia
Status
Recruiting
Phase
Phase 1/2
People taking part
30 people, planned
Started
31 Mar 2026
Expected to end
29 Dec 2028
Type of study
Interventional, 3 groups
Treatments tested
  • Instructed bedtime app-guided mindfulness meditation
  • Uninstructed app-guided mindfulness meditation
  • Sleep hygiene education
Record updated
23 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with long-lasting insomnia who mainly have trouble falling asleep. It tests a mindfulness meditation app against sleep habit education.

Age
18 years and older
Sex
All sexes
Disease stage
Chronic insomnia (≥ 3 nights/week, for ≥ 3 months), defined by DSM-V or ICSD-3. Main problem is falling asleep, taking more than 20 min. Insomnia Severity Index score ≥ 15.
Earlier treatment
People who practise mind-body methods twice a week or more cannot join. People now taking medicines that change sleep (such as anxiolytics/benzodiazepines, selective serotonin reuptake inhibitors, hypnotics) cannot join.

Main reasons for not taking part

  • Other sleep disorders, such as narcolepsy, restless leg syndrome or REM sleep behavior disorder
  • Shift work or regular night shifts
  • Pregnancy or breastfeeding
  • Pacemaker, or regular use of heart medicines that change heart rate, such as beta-blockers
  • Brain or nerve disorders, psychotic, substance use or trauma-related disorders, or hearing loss

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age 18 years and older
  • Chronic insomnia (≥ 3 nights/week, for ≥ 3 months), defined by DSM-V or ICSD-3
  • Have a primary complaint of difficulty falling asleep (sleep-onset insomnia) with self-reported sleep onset latency >20 min
  • Insomnia Severity Index score ≥ 15
  • Speak and understand English
  • Have a smart device (phone or tablet) for mobile app installation

Who cannot take part

  • Currently under medications with sleep changing effects (e.g., anxiolytics/benzodiazepines, selective serotonin reuptake inhibitors, hypnotics, etc.)
  • Hearing impairment or loss. Participants will be asked to report any medication for at least 2 weeks prior to study onset and during the study period
  • Current diagnosis of sleep disorders other than insomnia (e.g., narcolepsy, restless leg syndrome, REM sleep behavior disorder, etc.)
  • Patients with pace-maker or routinely using cardiovascular medications that have effects on heart rates (i.e., beta-blockers)
  • Neurological disorders (e.g. epilepsy, dementia, stroke, Parkinson's disease, neuroinfections, brain tumors, etc.) or current diagnosis of comorbid psychotic, substance use, and trauma-related disorders
  • Shift worker or routine night shifts
  • Women with pregnancy or breastfeeding
  • Regular (defined as twice a week or more) practice of mind-body interventions

Where in United States

  • Brigham and Women's HospitalBoston, United StatesContact: Yan MaTaking people

About the trial

What the trial wants to find out

The investigators will conduct a 3-arm, pilot RCT where participants (N=30) will be randomized in a 1:1:1 design to 4 weeks of instructed bedtime MM practice at night (n=10) vs. uninstructed MM (n=10) vs. sleep hygiene education only (n=10). Aim 1 is to understand the feasibility and acceptability of the intervention and study procedures. Aim 2 is to explore patterns of within-group changes in sleep outcomes (i.e., insomnia severity and sleep quality). Patient-reported outcomes will be collected using a HIPAA-compliant electronic data management system (REDCap). Following informed consent, participants will receive links to REDCap surveys via email at Weeks 0, 4, 8, and 16. The investigators will also conduct a post-intervention interview at the end of Week 4 and an exit interview at Week 16. All participants will also receive a research kit with wearable devices and meet with our staff after they receive the kit for instructions. Data collected in the pilot RCT will help us to preliminarily identify tools for subjective measures and physiological signals to inform a future trial.

The 3 groups in the trial

  • Instructed bedtime app-guided mindfulness meditationTreatment being tested

    Participants will utilize the specific sleep program available within the app, which will include a choice of audio soundtracks for guided MM (no exposure to screen lights during practice). The practice may involve techniques such as breathing exercise, imagery, body scan, and relaxation. Participants will specifically use the app during the immediate pre-sleep period. They can choose their preferred meditation sessions within the Sleep menu in Week 1-4.

    Treatment: Instructed bedtime app-guided mindfulness meditation and Sleep hygiene education

  • Uninstructed app-guided mindfulness meditationTreatment being tested

    Participants will be asked to practice MM using the same app during daytime (prior to the evening meal), but without specific study instructions around components to access or specific time of practice.

    Treatment: Uninstructed app-guided mindfulness meditation and Sleep hygiene education

  • Sleep Hygiene Education onlyOther group

    Participants will receive sleep hygiene education and asked not to start any new insomnia treatments. Sleep hygiene education serves as a minimal intervention control condition and real-world comparator. At the end of the study, interested participants in the control group will be given equal access to the mobile app. Usual care for insomnia typically involves sleep hygiene education, so all three groups will receive standard SHE as part of usual care.

    Treatment: Sleep hygiene education

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Pilot Feasibility and Acceptability RCT of an App-Based Mindfulness Meditation Intervention for Sleep Among Patients With Insomnia Disorder
Plain-language title
App-guided mindfulness meditation at bedtime for adults with insomniaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
23 June 2026